Product Information

AMLODIPINE-ATORVAST 10-10 MG is a generic product labeled by Apotex Corp., priced at $0.9964 per EA under NDC 60505347903. Its NADAC has been published 310 times since Sep 16, 2020.

FDA first approved this application on Nov 18, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

AMLODIPINE-ATORVAST 10-10 MG

Amlodipine and Atorvastatin
$0.9964per EA

Strength

10; 10 mg/1; mg/1

Manufacturer

Apotex Corp.

NDC

60505347903

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA205199

FDA Approved

11/18/2019

TE Code

AB

On Market Since

7/29/2020

Pharmacological Classes

Calcium Channel Antagonists
Calcium Channel Blocker
Cytochrome P450 3A Inhibitors
Dihydropyridine Calcium Channel Blocker
Dihydropyridines
HMG-CoA Reductase Inhibitor
Hydroxymethylglutaryl-CoA Reductase Inhibitors

Price Statistics

The NADAC for AMLODIPINE-ATORVAST 10-10 MG has been published 310 times since Sep 16, 2020, and over the history we have for it it has declined 68.0%. The table below summarizes its recorded NADAC range and movement.

Current price$0.9964 per EA
All-time high$3.1162 (Jan 13, 2021)
All-time low$0.6894 (Jul 17, 2024)
52-week high$1.6115
52-week low$0.9964
Median price$1.3851
Average price$1.5809
Largest weekly change+65.6% (Feb 22, 2023)
Weeks tracked310
Tracking sinceSep 16, 2020

Price History

1W

-2.8%

1M

-2.8%

3M

-7.6%

6M

-22.1%

1Y

-25.0%

3Y

-48.5%

5Y

-49.6%

All

-68.0%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of AMLODIPINE-ATORVAST 10-10 MG?

The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE-ATORVAST 10-10 MG, manufactured by Apotex Corp., is $0.9964 per EA (NDC 60505347903), effective Aug 19, 2026.

How has the price of AMLODIPINE-ATORVAST 10-10 MG changed over time?

Over the history we have for it, the NADAC for AMLODIPINE-ATORVAST 10-10 MG has declined 68.0%. It has been tracked across 310 weekly CMS publications since Sep 16, 2020.

What are the highest and lowest recorded NADAC prices for AMLODIPINE-ATORVAST 10-10 MG?

Since Sep 16, 2020, the NADAC for AMLODIPINE-ATORVAST 10-10 MG has ranged from a low of $0.6894 (Jul 17, 2024) to a high of $3.1162 (Jan 13, 2021), with a median of $1.3851 per EA.

Are there cheaper alternatives to AMLODIPINE-ATORVAST 10-10 MG?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as AMLODIPINE-ATORVAST 10-10 MG in a comparable dosage form, but none are currently priced below it.

Who manufactures AMLODIPINE-ATORVAST 10-10 MG?

AMLODIPINE-ATORVAST 10-10 MG (NDC 60505347903) is labeled by Apotex Corp., and CMS classifies it as a generic product.